29.72 -0.31 (-1.03%) | 09-10 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 35.86 | 1-year : | 41.89 |
Resists | First : | 30.7 | Second : | 35.86 |
Pivot price | 30 | |||
Supports | First : | 29.1 | Second : | 28.11 |
MAs | MA(5) : | 29.92 | MA(20) : | 29.72 |
MA(100) : | 26.89 | MA(250) : | 23.24 | |
MACD | MACD : | 0.5 | Signal : | 0.6 |
%K %D | K(14,3) : | 53.2 | D(3) : | 59.6 |
RSI | RSI(14): 55.8 | |||
52-week | High : | 30.7 | Low : | 17.75 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ PHG ] has closed above bottom band by 26.6%. Bollinger Bands are 62.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 29.8 - 29.96 | 29.96 - 30.1 |
Low: | 29.01 - 29.22 | 29.22 - 29.39 |
Close: | 29.41 - 29.72 | 29.72 - 29.99 |
Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Tue, 10 Sep 2024
World Stroke Organization and Philips call for action to expand access to life-saving stroke care - StockTitan
Thu, 05 Sep 2024
Here’s Why Koninklijke Philips N.V. (PHG) is on the Biggest Gainers List of Artisan Value Fund - Yahoo Finance
Tue, 25 Jun 2024
Philips Statistics By Country, NPS And Stock Price - Coolest Gadgets
Wed, 19 Jun 2024
Philips completes cancellation of 4.4 million shares - Philips
Wed, 15 May 2024
Philips announces exchange ratio for 2023 dividend - Philips
Wed, 01 May 2024
Koninklijke Philips Stock: Major Overhang Removed (NYSE:PHG) - Seeking Alpha
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NYSE
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Devices
|
|
Shares Out | 932 (M) |
Shares Float | 769 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 7.1 (%) |
Shares Short | 2,560 (K) |
Shares Short P.Month | 2,430 (K) |
EPS | -0.65 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 12.72 |
Profit Margin | -2.4 % |
Operating Margin | 6.2 % |
Return on Assets (ttm) | 1.3 % |
Return on Equity (ttm) | -4.6 % |
Qtrly Rev. Growth | -0.3 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 19.45 |
EBITDA (p.s.) | 1.48 |
Qtrly Earnings Growth | 585.2 % |
Operating Cash Flow | 1,800 (M) |
Levered Free Cash Flow | 1,850 (M) |
PE Ratio | -45.73 |
PEG Ratio | 0.9 |
Price to Book value | 2.33 |
Price to Sales | 1.52 |
Price to Cash Flow | 15.38 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |